| Jul 28 |
Wall Street Breakfast: The Week Ahead
|
| Jul 11 |
Down -88.84% in 4 Weeks, Here's Why HilleVax (HLVX) Looks Ripe for a Turnaround
|
| Jul 11 |
Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure
|
| Jul 9 |
(HLVX) - Analyzing HilleVax's Short Interest
|
| Jul 9 |
Stifel cuts HilleVax to hold, price target to $3 on failed study
|
| Jul 9 |
HilleVax (HLVX) Tanks as Norovirus Vaccine Study in Infants Fails
|
| Jul 8 |
US Equities Markets End Mixed as Investors Await Inflation Data
|
| Jul 8 |
Sector Update: Health Care Stocks Softer Late Afternoon
|
| Jul 8 |
HilleVax slides after company's HIL-214 vaccine for infants fails to meet main goal
|
| Jul 8 |
HilleVax’s norovirus vaccine ineffective in large trial of infants
|
